Atrium Therapeutics Inc (RNA)
Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 2,336 | 2,045 | 3,543 | 2,193 | 2,818 |
| Gross Profit | 2,336 | 2,045 | 3,543 | 2,193 | 2,818 |
| Operating Expenses | 23,273 | 20,731 | 13,898 | 16,119 | 13,729 |
| Operating Income | -20,937 | -18,686 | -10,355 | -13,926 | -10,911 |
| Other Income | -59,461 | -52,107 | -58,500 | -46,517 | -41,447 |
| Pre-tax Income | -80,398 | -70,793 | -68,855 | -60,443 | -52,358 |
| Net Income Continuous | -80,398 | -70,793 | -68,855 | -60,443 | -52,358 |
| Net Income | $-80,398 | $-70,793 | $-68,855 | $-60,443 | $-52,358 |
| EBITDA(a) | $-20,937 | $-18,686 | $-10,355 | $-13,926 | $-10,911 |